entertainment -WSS

entertainment

author：explore 2025-08-10 11:42:21 - browse：939

A photo of Robert Blum speaking at the STAT Summit West on May 16, 2024 — Cytokinetics CEO Robert Blum spoke last week at a talk during STAT’s Breakthrough Summit West in San Francisco. Sarah Gonzalez for STAT

Cytokinetics, a drugmaker that is expected to soon launch a promising new heart therapy called aficamten, said Wednesday that it had agreed to pay biotech firm Royalty Pharma a higher royalty on the medicine in return for up to $575 million, which will be used to fund the marketing of the drug and Cytokinetics’ ongoing research and development efforts.

Cytokinetics shares fell nearly 10% in after-hours trading after the announcement, which investors viewed as lowering the odds that the company will be purchased by a larger pharmaceutical company.

The firm also said that it would be raising $500 million through a stock sale.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Travel bans should be based on evidence, not politics or fear

WSS

Beware the threat of staffing cuts at the CDC

Congress must give Medicare recipients genetic counseling access

ActiGraph execs on goal of drug approvals with digital endpoints

Sage's campaign to raise awareness of postpartum depression hits a nerve

Zapping the brain for stroke rehab: Pivotal clinical trial begins

‘The Bear’ and hospitality in hospitals

entertainment

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

In Memoriam: Notable people who died in 2023

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Baltimore teen accused of firing into crowd during block party mass shooting

ChatGPT in medicine: STAT answers readers' burning questions

Hilary expected to bring catastrophic, life

Bright Health sells Medicare Advantage business to Molina

Zapping the brain for stroke rehab: Pivotal clinical trial begins

Novavax promises a turnaround & Lilly roils the obesity market

Former Georgia lieutenant governor says he received grand jury subpoena

explore

As Maui death toll rises, number of missing remains unclear

The painfully weak evidence on taking collagen to treat arthritis

Hilary expected to bring catastrophic, life

An Ebola outbreak presents a new mystery involving children

ActiGraph execs on goal of drug approvals with digital endpoints

FDA approves first treatment for ultra

hotspot

leisure time

hotspot

hotspot